ZA
CANO

Zazove Associates’s Cano Health, Inc. CANO Stock Holding History

Zazove Associates’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-250
Closed -$1K – 136
2023
Q4 		$1K Hold
250
– – ﹤0.01% 134
2023
Q3 		$6K Hold
250
– – ﹤0.01% 142
2023
Q2 		$35K Hold
250
– – ﹤0.01% 128
2023
Q1 		$23K Hold
250
– – ﹤0.01% 136
2022
Q4 		$34K Buy
+250
New +$84.6K ﹤0.01% 142

Other funds holding CANO

SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GFPC
Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Zazove Associates's CANO Position: Q1 2024 in Review

Zazove Associates sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 250 shares — an estimated $1K sold.

Zazove Associates first reported a position in CANO in Q4 2022 and held it in 5 quarters. The position peaked at $35K in Q2 2023. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Zazove Associates reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Zazove Associates sold 250 Cano Health, Inc. shares in Q1 2024, an estimated $1K.
  • Zazove Associates first reported a position in Cano Health, Inc. in Q4 2022 and held it in 5 quarters.
  • Zazove Associates's Cano Health, Inc. position peaked at $35K in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Zazove Associates's 13F filing for Q1 2024, filed 7 May 2024.